First Subject Dosed in Laquinimod Trial for Uveitis
Source: https://unsplash.com/photos/6F2mPewg2RA

First Subject Dosed in Laquinimod Trial for Uveitis

On December 10, 2021, biotechnology company Active Biotech shared that the first subject was dosed within a Phase 1 clinical trial evaluating laquinimod for non-infectious non-anterior uveitis. What is particularly…

Continue Reading First Subject Dosed in Laquinimod Trial for Uveitis
Researchers Discover a Potential Treatment For Meningitis Without Using Antibiotics
source: pixabay.com

Researchers Discover a Potential Treatment For Meningitis Without Using Antibiotics

A recent article in Science Daily reports that researchers at the Copenhagen and Lund Universities, using animal models, killed bacterial meningitis without the use of antibiotics. Estimates from the WHO…

Continue Reading Researchers Discover a Potential Treatment For Meningitis Without Using Antibiotics
Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma
Photo by Robina Weermeijer on Unsplash

Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma

Recently the Kidney Cancer Association held its International Kidney Cancer Symposium, where medical professionals and other industry members come together to share ideas and push for innovative research and treatments…

Continue Reading Study: Tivozanib As a Treatment for Advanced Renal Cell Carcinoma

Will Nivolumab Combined with Chemotherapy be the New Star in Controlling Advanced Gastric Cancer?

Platinum-based chemotherapy has been the standard treatment for patients with metastatic gastric adenocarcinoma for over ten years. According to a recent article in Healio, the median survival is about nine…

Continue Reading Will Nivolumab Combined with Chemotherapy be the New Star in Controlling Advanced Gastric Cancer?
COVID-19 May Be a Trigger for the Development of Anti-Glomerular Basement Membrane Disease
source: pixabay.com

COVID-19 May Be a Trigger for the Development of Anti-Glomerular Basement Membrane Disease

According to a recent journal, a case study found that the development of anti-glomerular basement membrane disease (anti-GBM) may be triggered by COVID-19. Anti-Glomerular Basement Membrane Disease Anti-glomerular basement membrane…

Continue Reading COVID-19 May Be a Trigger for the Development of Anti-Glomerular Basement Membrane Disease